Chuck Wiseman, MD, BriaCell Therapeutics, discusses Capitalizing on Matching HL-Antigens Key to developing clinically relevant immune response at Annual Meeting 2018
Capitalize on Matching HL-Antigens Key to developing clinically relevant immune response
